Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis

(2015) Antoine François et al.   JOURNAL OF AUTOIMMUNITY

C-X-C Motif Chemokine 13 (CXCL13) Is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis

(2014) Louis J. Vuga et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Identification of Annexin 1 as a Novel Autoantigen in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

(2014) K. Kurosu et al.   JOURNAL OF IMMUNOLOGY

Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis

(2014) Daryle J DePianto et al.   THORAX

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

(2013) William D. Travis et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Plasma B Lymphocyte Stimulator and B Cell Differentiation in Idiopathic Pulmonary Fibrosis Patients

(2013) J. Xue et al.   JOURNAL OF IMMUNOLOGY

Type V Collagen Induced Tolerance Suppresses Collagen Deposition, TGF-β and Associated Transcripts in Pulmonary Fibrosis

(2013) Ragini Vittal et al.   PLoS One

Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis

(2013) J. D. Herazo-Maya et al.   Science Translational Medicine

Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses

(2012) Rehan A. Kahloon et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Acute Exacerbation of Idiopathic Pulmonary Fibrosis

(2012) Dong Soon Kim   CLINICS IN CHEST MEDICINE

Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy

(2012) Gregory J. Keir et al.   EUROPEAN RESPIRATORY JOURNAL

Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases

(2012) Elisa Corsiero et al.   IMMUNOLOGY LETTERS

Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases

(2012) Erwin W. Gelfand   NEW ENGLAND JOURNAL OF MEDICINE

Signaling pathways in aged T cells – A reflection of T cell differentiation, cell senescence and host environment

(2012) Jörg J. Goronzy et al.   SEMINARS IN IMMUNOLOGY

Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis

(2011) Thomas J. Richards et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis

(2011) Gerard J Nuovo et al.   MODERN PATHOLOGY

The HLA Class II Allele DRB1*1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis

(2011) Jianmin Xue et al.   PLoS One

Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis

(2010) Camille Taillé et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Rheumatoid Arthritis: A Role for Immunosenescence?

(2010) Tamsin M. Lindstrom et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis

(2010) Syed R. Gilani et al.   PLoS One

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)

(2010) Johannes Brettschneider et al.   PLoS One

B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B cell maturation antigen-immunoglobulin

(2010) Stacey R Dillon et al.   ARTHRITIS RESEARCH & THERAPY

Mechanisms of Immune Complex–Mediated Neutrophil Recruitment and Tissue Injury

(2009) Tanya N. Mayadas et al.   CIRCULATION

Rituximab therapy in autoimmune pulmonary alveolar proteinosis

(2009) R. Borie et al.   EUROPEAN RESPIRATORY JOURNAL

The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus

(2009) Michael P. Cancro et al.   JOURNAL OF CLINICAL INVESTIGATION

Serum BLC/CXCL13 Concentrations and Renal Expression of CXCL13/CXCR5 in Patients with Systemic Lupus Erythematosus and Lupus Nephritis

(2009) H.-T. LEE et al.   JOURNAL OF RHEUMATOLOGY

Rituximab treatment of the anti-synthetase syndrome—a retrospective case series

(2009) Marthe Sem et al.   RHEUMATOLOGY

Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor

(2009) M Margarida Souto-Carneiro et al.   ARTHRITIS RESEARCH & THERAPY

Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor α, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor

(2008) Inmaculada Rioja et al.   ARTHRITIS AND RHEUMATISM

Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95

(2008) Annett M. Jacobi et al.   ARTHRITIS AND RHEUMATISM

Infections and Autoimmunity: A Panorama

(2008) V. Pordeus et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY